You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
AstraZeneca
Merck
Boehringer Ingelheim
Johnson and Johnson

Last Updated: May 16, 2021

DrugPatentWatch Database Preview

NPLATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: NPLATE
Patents:26
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for NPLATE
Recent Clinical Trials for NPLATE

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Anjali SharathkumarEarly Phase 1
AmgenEarly Phase 1
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyPhase 2

See all NPLATE clinical trials

Pharmacology for NPLATE

Company Disclosures: US Patents for NPLATE

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22   Get Started for $10 Amgen Inc. (Thousand Oaks, CA) 2018-10-23 RX company
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22   Get Started for $10 Amgen Inc. (Thousand Oaks, CA) 2018-10-23 RX company
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22   Get Started for $10 Amgen Inc. (Thousand Oaks, CA) 2018-10-23 RX company
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22   Get Started for $10 Amgen Inc. (Thousand Oaks, CA) 2018-10-23 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for NPLATE

These patents were identified by searching patent claims

Supplementary Protection Certificates for NPLATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
SZ 25/2009 Austria   Get Started for $10 PRODUCT NAME: ROMIPLOSTIM
C01124961/01 Switzerland   Get Started for $10 FORMER REPRESENTATIVE: BOHEST AG, CH
09C0030 France   Get Started for $10 PRODUCT NAME: ROMIPLOSTIM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204
PA2009006,C1124961 Lithuania   Get Started for $10 PRODUCT NAME: ROMIPLOSTIMUM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204
300398 Netherlands   Get Started for $10 300398, 20191022, EXPIRES: 20240203
2009/022 Ireland   Get Started for $10 PRODUCT NAME: ROMIPLOSTIM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.